Case Reports Open access

Acquired Haemophilia A. Which is the best therapeutic choice in older adults? Single center study of 4 cases

Authors

Published
1 April 2019
Section
Case Reports
DOI
10.4081/reumatismo.2019.1041
Pages
37-41

Abstract

Acquired haemophilia A (AHA) is a rare bleeding disorder due to autoantibodies directed against coagulation factor VIII. The treatment is based on recombinant activated factor VII and activated prothrombin complex concentrate. However, mainly in older patients, severe thrombotic complications have been reported. Here we report the different therapeutic approaches in 4 cases of elderly patients with AHA and co-morbidities.

Keywords

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.